BMG LABTECH Invests 4.5 Million Euro in Headquarters Site Expansion
News Aug 30, 2016
BMG LABTECH has recorded a rapid increase in revenue over the past years. A new company building provides the additional capacity required for the company's anticipated business growth over the longer term. The expansion is a necessary response to the global demand for BMG LABTECH products and technologies made in Germany.
The new building is designed to double the manufacturing area and provide new space for warehouse capacities, research and development and the planned job growth. The new capabilities will ensure that BMG LABTECH can continue to meet demand while also developing new products to suit customer needs.
BMG LABTECH is at the forefront of technology offering microplate readers for life sciences applications and high-throughput screening. The company is on a steady course of growth due to continuous development of innovative and unique technologies over the past 25 years.
BMG LABTECH employs 110 people at its headquarters and its five subsidiaries in Australia, France, UK, Japan, and the US. More than 50 distributors provide additional product, technical and software support all over the world.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE